The placebo effect in allergen-specific immunotherapy trials

BACKGROUND: Double-blind, placebo-controlled (DBPC) trials are the gold standard for demonstrating clinical efficacy and tolerability. The placebo effect, although an important feature in placebo-controlled studies, has never been systematically investigated in allergen-specific immunotherapy (SIT)...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Narkus, Annemie, Lehnigk, Ulrike, Haefner, Dietrich, Klinger, Regine, Pfaar, Oliver, Worm, Margitta
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2013
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3878370/
https://ncbi.nlm.nih.gov/pubmed/24360060
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2045-7022-3-42
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia